We are live on
!
Find out more
SC
Saturna Capital Portfolio holdings
AUM
$7.13B
1-Year Est. Return
35.47%
This Fund
S&P 500
This Quarter
Est. Return
+3.58%
1 Year Est. Return
+35.47%
3 Year Est. Return
+92.6%
5 Year Est. Return
+130.56%
10 Year Est. Return
+515.97%
AUM
$7.65B
AUM Growth
+$112M
(+1.5%)
Cap. Flow
-$72.9M
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
44.49%
Holding
170
New
4
Increased
63
Reduced
46
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$105M |
| 2 |
Kenvue
KVUE
|
+$6.36M |
| 3 |
Broadcom
AVGO
|
+$2.78M |
| 4 |
Microsoft
MSFT
|
+$1.16M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$671K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$80.4M |
| 2 |
Eli Lilly
LLY
|
+$30.1M |
| 3 |
Cisco
CSCO
|
+$22.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$12.1M |
| 5 |
Apple
AAPL
|
+$10M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 46.65% |
| 2 | Healthcare | 23.02% |
| 3 | Industrials | 12.1% |
| 4 | Consumer Staples | 6.52% |
| 5 | Consumer Discretionary | 6.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Phillips 66
PSX
$83.7B
| $227K | ﹤0.01% |
1,729
+229
| +15% | +$30.9K |
|
152
PayPal
PYPL
$50.7B
| $226K | ﹤0.01% |
+2,900
| New | +$194K |
|
153
Micron Technology
MU
$874B
| $226K | ﹤0.01% |
2,175
| – | – |
|
154
Microchip Technology
MCHP
$39.2B
| $212K | ﹤0.01% |
2,635
-30
| -1% | -$2.48K |
|
155
Fortune Brands Innovations
FBIN
$5.9B
| $210K | ﹤0.01% |
+2,350
| New | +$180K |
|
156
SiTime
SITM
$14.1B
| $206K | ﹤0.01% |
+1,200
| New | +$172K |
|
157
Iovance Biotherapeutics
IOVA
$2.07B
| $193K | ﹤0.01% |
20,553
+1,353
| +7% | +$12.8K |
|
158
Haleon
HLN
$45.1B
| $122K | ﹤0.01% |
11,500
| – | – |
|
159
Booking.com
BKNG
$157B
| – | – |
-1,700
| Closed | -$269K |
|
|
CFLT
160
DELISTED
Confluent
CFLT
| – | – |
-8,700
| Closed | -$257K |
|
161
CrowdStrike
CRWD
$184B
| – | – |
-4,524
| Closed | -$433K |
|
162
Chevron
CVX
$383B
| – | – |
-1,852
| Closed | -$290K |
|
163
Elastic
ESTC
$6.73B
| – | – |
-2,192
| Closed | -$250K |
|
164
Freeport-McMoran
FCX
$85.9B
| – | – |
-6,754
| Closed | -$328K |
|
|
165
Alphabet (Google) Class C
GOOG
$4.12T
| – | – |
-1,325
| Closed | -$243K |
|
166
Honeywell
HON
$76.8B
| – | – |
-1,061
| Closed | -$214K |
|
|
167
Idexx Laboratories
IDXX
$45B
| – | – |
-165,072
| Closed | -$80.4M |
|
168
Raymond James Financial
RJF
$33.9B
| – | – |
-7,352
| Closed | -$909K |
|
169
Toronto Dominion Bank
TD
$195B
| – | – |
-4,500
| Closed | -$247K |
|
170
Telus
TU
$17.1B
| – | – |
-13,200
| Closed | -$200K |
|
Similar funds
FPA
TSC
MNA
UB
FPP
NAMA
CFG
LP
Saturna Capital's Q3 2024 Portfolio in Review
As of Q3 2024, Saturna Capital held 170 positions worth $7.65B, up 1.5% from $7.53B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Saturna Capital's Q3 2024 filing shows 4 new, 63 increased, 46 reduced and 12 closed positions. Its largest new stake was Argan: 3,894 shares worth $395K. The largest sale was Idexx Laboratories, an estimated $80.4M.
By sector, the portfolio is most concentrated in Technology at 47% of assets, down from 47% a quarter earlier, followed by Healthcare and Industrials.
- Saturna Capital's largest Q3 2024 buy was Argan: 3,894 shares worth $395K.
- Saturna Capital added most to AbbVie in Q3 2024, an estimated $105M increase.
- Saturna Capital's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $30.1M.
- Saturna Capital fully exited Idexx Laboratories in Q3 2024, selling an estimated $80.4M.
- Saturna Capital's ten largest holdings make up 44% of its $7.65B portfolio in Q3 2024.
- Saturna Capital opened 4 new positions and closed 12 in Q3 2024.
- Saturna Capital's portfolio value rose 1.5% quarter-over-quarter to $7.65B.
Based on Saturna Capital's 13F filing for Q3 2024, filed 5 Nov 2024.